- Home
- Publications
- Publication Search
- Publication Details
Title
Expression and clinical significance of Wee1 in colorectal cancer
Authors
Keywords
Wee1, S100A4, Colorectal cancer, Prognostic marker
Journal
TUMOR BIOLOGY
Volume 37, Issue 9, Pages 12133-12140
Publisher
Springer Nature
Online
2016-05-25
DOI
10.1007/s13277-016-5081-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma
- (2015) Gry Irene Magnussen et al. BMC CANCER
- Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes
- (2015) Eivind Valen Egeland et al. CLINICAL & EXPERIMENTAL METASTASIS
- WEE1 Kinase As a Target for Cancer Therapy
- (2015) Sabine Mueller et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors
- (2015) Khanh Do et al. JOURNAL OF CLINICAL ONCOLOGY
- Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions
- (2014) Ana Slipicevic et al. GYNECOLOGIC ONCOLOGY
- Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney
- (2014) Sander A. Huisman et al. INTERNATIONAL JOURNAL OF CANCER
- The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer
- (2014) Lutfiye Demir et al. JOURNAL OF SURGICAL ONCOLOGY
- Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy
- (2013) A. D. Guertin et al. MOLECULAR CANCER THERAPEUTICS
- Cell Cycle Proteins Predict Recurrence in Stage II and III Colon Cancer
- (2012) Eric J. Th. Belt et al. ANNALS OF SURGICAL ONCOLOGY
- EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer
- (2012) K Boye et al. BRITISH JOURNAL OF CANCER
- Combined inhibition of Chk1 and Wee1: In vitro synergistic effect translates to tumor growth inhibition in vivo
- (2012) Laura Carrassa et al. CELL CYCLE
- High Expression of Wee1 Is Associated with Poor Disease-Free Survival in Malignant Melanoma: Potential for Targeted Therapy
- (2012) Gry Irene Magnussen et al. PLoS One
- Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
- (2012) Marieke Aarts et al. Cancer Discovery
- Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation
- (2011) Kurtis D. Davies et al. CANCER BIOLOGY & THERAPY
- WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe
- (2011) P. C. De Witt Hamer et al. CLINICAL CANCER RESEARCH
- Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease
- (2011) Raquel Domínguez-Kelly et al. JOURNAL OF CELL BIOLOGY
- In Silico Analysis of Kinase Expression Identifies WEE1 as a Gatekeeper against Mitotic Catastrophe in Glioblastoma
- (2010) Shahryar E. Mir et al. CANCER CELL
- Asymmetric localization of the CDC25B phosphatase to the mother centrosome during interphase
- (2010) Rose Boutros et al. CELL CYCLE
- Nuclear S100A4 is a novel prognostic marker in colorectal cancer
- (2010) Kjetil Boye et al. EUROPEAN JOURNAL OF CANCER
- S100A4 and Metastasis
- (2009) Kjetil Boye et al. AMERICAN JOURNAL OF PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started